Editor's Note: The fourth China International Import Expo in November 2021 saw purchasers play a significant part in the expo's success by clinching a large number of deals with exhibitors. Many purchasers have since shared about their gains and expressed confidence in the annual event.

Song Lulu, deputy general manager of Shanghai Pharmaceutical Co

Shanghai Pharmaceutical Co specializes in pharmaceutical distribution and has expanded its business to 17 provinces and municipalities in China.

Q: What did your company gain from the fourth CIIE?

A: We signed purchase agreements with a number of international big pharmas and the total value of the deals was larger than before. We will continue to introduce the newest medication from leading pharmaceutical companies to help Chinese patients.

Q: What impressed you the most during the fourth CIIE?

A: The fact that the expo was held as planned despite the COVID-19 pandemic. This showed that China is opening up to the world and taking on its responsibilities as a major country.

Q: Why have you attended the expo multiple times?

A: We have participated in the CIIE since the inaugural edition in 2018. The expo demonstrates the dynamism of the Chinese market and China's commitment to cooperation, which strengthens the confidence that multinational pharmaceutical companies have in the country.

Many big pharmas display their latest medication and equipment at the expo. We can help match them with Chinese patients.